Kezia Parkins is the lead editor for Medical Device Network and Medical Technology Magazine.
She is an experienced healthcare writer and editor with special interests in MedTech, clinical trials, patient centricity and global health equality.
Women tend to be harder to recruit for clinical trials due to socioeconomic factors. But decentralised study designs help ease barriers to participation.
Many untapped AI opportunities in clinical trials, considering companies mainly focus on drug discovery and repurposing.
eConsent and web-based questionnaires have largest growth, but telemedicine and mobile-based elements remain as pillars.
We spoke to four leaders harnessing AI in clinical trials about its challenges and their vision for AI in the future.
Innovation Fund Denmark invests in high-risk, high-potential innovation to improve the lives of the Danish population.
Give your business an edge with our leading industry insights.
Lifeology is harnessing the art of visual storytelling to help fight mistrust and misinformation in the age of the ‘infodemic.’
Health policy professor Dr Huseyin Naci discusses the risks of leaning too hard on surrogate endpoints in clinical research.
NIMH’s Dr Elizabeth Ballard discusses how ketamine has laid the groundwork for a new paradigm of suicide research.
A cure for Type 1 diabetes has come one step closer as Vertex reports 90-day results for its synthetic insulin cell therapy.
Hawthorne Effect’s Hero network is enabling continuous data capture in remote and hard to reach communities.